Article info
PDFOriginal articles
Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?
- Correspondence to Sven Gunia, Institute of Pathology at the Johanniter Hospital Stendal, Straße der Demokratie 1, Stendal 39576, Germany; sven-gunia{at}gmx.de
Citation
Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?
Publication history
- Received August 9, 2012
- Revised September 14, 2012
- Accepted September 23, 2012
- First published October 26, 2012.
Online issue publication
August 11, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions